$MXL
MAXLINEAR, INC

2013 Q2 Form 10-Q Financial Statement

#000128846913000003 Filed on August 01, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $29.77M $24.42M
YoY Change 21.92% 34.96%
Cost Of Revenue $12.48M $9.298M
YoY Change 34.19% 38.78%
Gross Profit $17.30M $15.12M
YoY Change 14.38% 32.24%
Gross Profit Margin 58.09% 61.92%
Selling, General & Admin $7.768M $6.626M
YoY Change 17.24% 47.24%
% of Gross Profit 44.91% 43.82%
Research & Development $12.32M $11.00M
YoY Change 12.01% -13.43%
% of Gross Profit 71.2% 72.71%
Depreciation & Amortization $1.000M $800.0K
YoY Change 25.0% 14.29%
% of Gross Profit 5.78% 5.29%
Operating Expenses $20.08M $17.62M
YoY Change 13.97% 3.05%
Operating Profit -$2.787M -$2.499M
YoY Change 11.52% -55.89%
Interest Expense $0.00 $15.00K
YoY Change -100.0% -85.0%
% of Operating Profit
Other Income/Expense, Net -$44.00K $3.000K
YoY Change -1566.67%
Pretax Income -$2.773M -$2.429M
YoY Change 14.16% -56.63%
Income Tax $131.0K $130.0K
% Of Pretax Income
Net Earnings -$2.904M -$2.559M
YoY Change 13.48% -46.64%
Net Earnings / Revenue -9.75% -10.48%
Basic Earnings Per Share -$0.09 -$0.08
Diluted Earnings Per Share -$0.09 -$0.08
COMMON SHARES
Basic Shares Outstanding 33.75M shares 33.58M shares
Diluted Shares Outstanding 33.75M shares 33.58M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $61.80M $81.30M
YoY Change -23.99% -10.76%
Cash & Equivalents $24.72M $12.51M
Short-Term Investments $37.10M $68.80M
Other Short-Term Assets $1.800M $1.600M
YoY Change 12.5% -62.79%
Inventory $9.355M $8.500M
Prepaid Expenses
Receivables $17.86M $14.90M
Other Receivables $0.00 $0.00
Total Short-Term Assets $90.83M $106.4M
YoY Change -14.64% -3.62%
LONG-TERM ASSETS
Property, Plant & Equipment $6.149M $5.400M
YoY Change 13.87% 3.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $19.50M $3.000M
YoY Change 550.0%
Other Assets $267.0K $200.0K
YoY Change 33.5% -96.55%
Total Long-Term Assets $26.83M $9.300M
YoY Change 188.46% -20.51%
TOTAL ASSETS
Total Short-Term Assets $90.83M $106.4M
Total Long-Term Assets $26.83M $9.300M
Total Assets $117.7M $115.7M
YoY Change 1.69% -5.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.304M $6.800M
YoY Change 22.12% 3.03%
Accrued Expenses $4.857M $16.50M
YoY Change -70.56% 142.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $30.80M $25.50M
YoY Change 20.8% 47.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $903.0K $700.0K
YoY Change 29.0% -46.15%
Total Long-Term Liabilities $903.0K $700.0K
YoY Change 29.0% -46.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.80M $25.50M
Total Long-Term Liabilities $903.0K $700.0K
Total Liabilities $31.71M $26.20M
YoY Change 21.02% 40.11%
SHAREHOLDERS EQUITY
Retained Earnings -$64.22M
YoY Change
Common Stock $150.2M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $85.95M $89.50M
YoY Change
Total Liabilities & Shareholders Equity $117.7M $115.7M
YoY Change 1.69% -5.24%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$2.904M -$2.559M
YoY Change 13.48% -46.64%
Depreciation, Depletion And Amortization $1.000M $800.0K
YoY Change 25.0% 14.29%
Cash From Operating Activities $6.200M $1.000M
YoY Change 520.0% -350.0%
INVESTING ACTIVITIES
Capital Expenditures -$2.000M -$800.0K
YoY Change 150.0% -20.0%
Acquisitions
YoY Change
Other Investing Activities $3.300M -$12.50M
YoY Change -126.4% 15.74%
Cash From Investing Activities $1.300M -$13.20M
YoY Change -109.85% 10.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 1.000M
YoY Change -100.0% 0.0%
NET CHANGE
Cash From Operating Activities 6.200M 1.000M
Cash From Investing Activities 1.300M -13.20M
Cash From Financing Activities 0.000 1.000M
Net Change In Cash 7.500M -11.20M
YoY Change -166.96% -0.88%
FREE CASH FLOW
Cash From Operating Activities $6.200M $1.000M
Capital Expenditures -$2.000M -$800.0K
Free Cash Flow $8.200M $1.800M
YoY Change 355.56% 200.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
8304000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7372000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14558000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17855000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-481000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-550000 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4857000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5023000 USD
CY2013Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
453000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5291000 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4655000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4494000 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4290000 shares
CY2013Q2 us-gaap Assets
Assets
117653000 USD
CY2012Q4 us-gaap Assets
Assets
110597000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
98018000 USD
CY2012Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
60089000 USD
CY2013Q2 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
43000 USD
CY2012Q4 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
4000 USD
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
386000 USD
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9424000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8299000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
35000 USD
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
150164000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
139210000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6128000 USD
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3339000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4556000 USD
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2333000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
90826000 USD
CY2013Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
60161000 USD
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
60084000 USD
CY2013Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
34900000 USD
CY2013Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
37084000 USD
CY2012Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
50265000 USD
CY2013Q2 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
60121000 USD
CY2013Q2 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions
24 debt_security
CY2013Q2 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
19453000 USD
CY2012Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
5181000 USD
CY2013Q2 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
3000 USD
CY2012Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
9000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
254000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
425000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21810000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24718000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28026000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12512000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2908000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-15514000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
8000 USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4369000 USD
CY2013Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
0 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
0 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2564000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2933000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9107000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5240000 USD
us-gaap Cost Of Revenue
CostOfRevenue
22299000 USD
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
12477000 USD
us-gaap Cost Of Revenue
CostOfRevenue
17628000 USD
CY2012Q2 us-gaap Cost Of Revenue
CostOfRevenue
9298000 USD
CY2012Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
1469000 USD
CY2013Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
1434000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2042000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1701000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
7000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7004000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
17296000 USD
us-gaap Gross Profit
GrossProfit
27475000 USD
us-gaap Gross Profit
GrossProfit
34008000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
15122000 USD
CY2013Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
208000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
112000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
319000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
319000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
958000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
275000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4993000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2773000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2429000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8930000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
131000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
130000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
191000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
211000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3309000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
36000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4527000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3297000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2201000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2165000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
455000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-536000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-179000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
114000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
330000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
237000 USD
CY2012Q2 us-gaap Interest Expense
InterestExpense
15000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
34000 USD
us-gaap Interest Expense
InterestExpense
4000 USD
CY2013Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6019000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6658000 USD
CY2013Q2 us-gaap Investments And Cash
InvestmentsAndCash
81255000 USD
CY2012Q4 us-gaap Investments And Cash
InvestmentsAndCash
77256000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
110597000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
117653000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
9355000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
9891000 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3233000 USD
CY2013Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
3336000 USD
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
82000 USD
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
58000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
147000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
117000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
30803000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
29568000 USD
CY2013Q2 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1034000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16430000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4094000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-125000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7006000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-2559000 USD
us-gaap Net Income Loss
NetIncomeLoss
-5204000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-2904000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9121000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
20077000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
17621000 USD
us-gaap Operating Expenses
OperatingExpenses
36488000 USD
us-gaap Operating Expenses
OperatingExpenses
38991000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4983000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9013000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2781000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2499000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1055000 USD
CY2013Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1025000 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
1195000 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
71000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
267000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
257000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-29000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
14000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-36000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-45000 USD
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-33000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
8000 USD
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6000 USD
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
6000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
903000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
796000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-123000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-50000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000 USD
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
0 USD
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
4836000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1123000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
69000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
47117000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
57460000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
195000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
655000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1626000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1822000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1814000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1494000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
45500000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15165000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1113000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1132000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
42851000 USD
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15573000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6866000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6149000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
29000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
2000 USD
CY2012Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
10995000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
23820000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
22903000 USD
CY2013Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
12309000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59015000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-64219000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
29773000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
56307000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
45103000 USD
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
24420000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13585000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6626000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7768000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15171000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6128000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4556000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
85947000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
80233000 USD
CY2013Q2 mxl Deferred Revenue Rebates
DeferredRevenueRebates
44000 USD
CY2013Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
100000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes of the unaudited consolidated financial statements. Actual results could differ from those estimates.</font></div></div>
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2012Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2013Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33748000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33445000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33287000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33578000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33287000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33445000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33748000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33578000 shares
CY2013Q2 mxl Accrued Litigation Fees Current
AccruedLitigationFeesCurrent
379000 USD
CY2012Q4 mxl Accrued Litigation Fees Current
AccruedLitigationFeesCurrent
586000 USD
CY2013Q2 mxl Accrued Price Protection Liability
AccruedPriceProtectionLiability
10677000 USD
CY2012Q4 mxl Accrued Price Protection Liability
AccruedPriceProtectionLiability
7880000 USD
CY2012Q2 mxl Accrued Price Protection Liability
AccruedPriceProtectionLiability
6702000 USD
CY2011Q4 mxl Accrued Price Protection Liability
AccruedPriceProtectionLiability
2840000 USD
CY2013Q2 mxl Accrued Technology License Payments Current
AccruedTechnologyLicensePaymentsCurrent
3000000 USD
CY2012Q4 mxl Accrued Technology License Payments Current
AccruedTechnologyLicensePaymentsCurrent
2996000 USD
CY2013Q2 mxl Deferred Revenue And Deferred Profit
DeferredRevenueAndDeferredProfit
2596000 USD
CY2012Q4 mxl Deferred Revenue And Deferred Profit
DeferredRevenueAndDeferredProfit
2289000 USD
CY2012Q4 mxl Deferred Revenue Distributor Transactions
DeferredRevenueDistributorTransactions
3735000 USD
CY2013Q2 mxl Deferred Revenue Distributor Transactions
DeferredRevenueDistributorTransactions
3986000 USD
mxl Price Protection Rebate Charges
PriceProtectionRebateCharges
5692000 USD
mxl Price Protection Rebate Charges
PriceProtectionRebateCharges
9922000 USD
CY2012Q4 mxl Deferred Revenue Rebates
DeferredRevenueRebates
23000 USD
mxl Deferred Revenueand Deferred Profits
DeferredRevenueandDeferredProfits
307000 USD
mxl Deferred Revenueand Deferred Profits
DeferredRevenueandDeferredProfits
-1804000 USD
mxl Increase Decreasein Accrued Price Protection Liability
IncreaseDecreaseinAccruedPriceProtectionLiability
2797000 USD
mxl Increase Decreasein Accrued Price Protection Liability
IncreaseDecreaseinAccruedPriceProtectionLiability
3846000 USD
mxl Intangible Asset Expenditures Irrcuredbut Notyet Paid
IntangibleAssetExpendituresIrrcuredbutNotyetPaid
300000 USD
mxl Intangible Asset Expenditures Irrcuredbut Notyet Paid
IntangibleAssetExpendituresIrrcuredbutNotyetPaid
0 USD
mxl Number Of Class Of Stock Outstanding
NumberOfClassOfStockOutstanding
2 class
CY2012Q3 mxl Number Of Patents In Connection With Patent Infringement Matters
NumberOfPatentsInConnectionWithPatentInfringementMatters
3 patent
CY2012Q3 mxl Number Of Patents In Connection With Patent Infringement Matters
NumberOfPatentsInConnectionWithPatentInfringementMatters
19 patent
CY2013Q2 mxl Number Of Patents In Connection With Patent Infringement Matters
NumberOfPatentsInConnectionWithPatentInfringementMatters
19 patent
CY2013Q2 mxl Number Of Patents In Connection With Patent Infringement Matters Additiona
NumberOfPatentsInConnectionWithPatentInfringementMattersAdditiona
1 patent
CY2013Q2 mxl Number Of Patents In Connection With Patent Infringement Matterscounterclaims
NumberOfPatentsInConnectionWithPatentInfringementMatterscounterclaims
5 patent
CY2013Q2 mxl Percentage Of Revenue From Companys Distributors
PercentageOfRevenueFromCompanysDistributors
0.33
mxl Percentage Of Revenue From Companys Distributors
PercentageOfRevenueFromCompanysDistributors
0.41
mxl Percentage Of Revenue From Companys Distributors
PercentageOfRevenueFromCompanysDistributors
0.31
CY2012Q2 mxl Percentage Of Revenue From Companys Distributors
PercentageOfRevenueFromCompanysDistributors
0.35
mxl Period Of Change Of Unrecognized Tax Benefits
PeriodOfChangeOfUnrecognizedTaxBenefits
P12M
mxl Price Protectionpayments
PriceProtectionpayments
-7125000 USD
mxl Price Protectionpayments
PriceProtectionpayments
-1830000 USD
CY2013Q2 mxl Production Mask Impairment Charge
ProductionMaskImpairmentCharge
1100000 USD
mxl Share Based Compensation Arrangement By Share Based Payment Award Award Expiration Period Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExpirationPeriodMaximum
P10Y
mxl Share Based Compensation Arrangement By Share Based Payment Award Expiration Period Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriodMinimum
P7Y
mxl Share Based Payment Award Exercise Price As Percentage Of Common Stock Fair Value Minimum
ShareBasedPaymentAwardExercisePriceAsPercentageOfCommonStockFairValueMinimum
1.00
CY2013Q2 mxl Shares Issuedupon Settlementof Executive Bonus Plan
SharesIssueduponSettlementofExecutiveBonusPlan
800000 shares
CY2013Q2 mxl Taxable Income Adjustment From Tax Examination
TaxableIncomeAdjustmentFromTaxExamination
0 USD
mxl Term Of Invoice Of Distributor
TermOfInvoiceOfDistributor
P30D
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001288469
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
MAXLINEAR INC
dei Trading Symbol
TradingSymbol
MXL

Files In Submission

Name View Source Status
0001288469-13-000003-index-headers.html Edgar Link pending
0001288469-13-000003-index.html Edgar Link pending
0001288469-13-000003.txt Edgar Link pending
0001288469-13-000003-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
mxl-20130630.xml Edgar Link completed
mxl-20130630.xsd Edgar Link pending
mxl-20130630_cal.xml Edgar Link unprocessable
mxl-20130630_def.xml Edgar Link unprocessable
mxl-20130630_lab.xml Edgar Link unprocessable
mxl-20130630_pre.xml Edgar Link unprocessable
mxl-2013630x10q.htm Edgar Link pending
mxl-2013630xex311.htm Edgar Link pending
mxl-2013630xex312.htm Edgar Link pending
mxl-2013630xex321.htm Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending